Analysis updated on Nov. 6, 2026 (UTC) · Total · absolute moveSwitch to Alpha · Nasdaq
Our AI scores Vivani Medical, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Vivani Medical, Inc. is a small-cap company with a market capitalization of $94M. It ranks number 13 by market capitalization among the 28 Electromedical & Electrotherapeutic Apparatus issuers in our coverage with a current forecast.
For VANI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -8.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 10.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +6.2%, buy ≥ +4.2%, sell < +2.2%, strong sell < +0.5% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, VANI included.
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Electromedical & Electrotherapeutic Apparatus peers listed below that report each metric.
| Metric | VANI | Rank |
|---|---|---|
| Market Cap | $94M | 13/28 |
| P/B Ratio | 4.95x | 7/22 |
| EPS | $-0.38 | – |
| Book Value/Share | $0.21 | – |
| FCF/Share | $-0.29 | – |
| Metric | VANI | Rank |
|---|---|---|
| ROE | -138.7% | 13/15 |
| ROA | -63.2% | 13/18 |
| ROIC | -77.8% | 18/20 |
| Tax Rate | -0.0% | – |
| Metric | VANI | Rank |
|---|---|---|
| Current Ratio | 3.25x | 11/27 |
| D/E Ratio | 1.20x | 7/23 |
| Financial Leverage | 2.20x | 7/23 |
| Interest Coverage | -1164.2x | 27/27 |
| Working Capital | $15M | 14/26 |
| Metric | VANI | Rank |
|---|---|---|
| Operating Cash Flow | -$25M | 23/27 |
| Free Cash Flow | -$26M | 10/14 |
| Capital Spending | -$1M | 8/14 |
| Metric | VANI | Rank |
|---|---|---|
| Operating Income | -$27M | 22/27 |
| Net Income | -$26M | 17/19 |
| R&D Expense | $18M | 10/26 |
| Metric | VANI | Rank |
|---|---|---|
| Shares Outstanding | 90M | – |
| Total Current Assets | $22M | 52.0% of assets |
| Cash & Short-term Investments | $20M | 47.8% of assets |
| Total Liabilities | $23M | 54.5% of assets |
| Short-term Debt | $5M | 13.1% of assets |
Companies classified under the same SEC industry code as Vivani Medical, Inc. (Electromedical & Electrotherapeutic Apparatus): 29 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| VANI Vivani Medical, Inc. | $94M | |
| MDT Medtronic Plc | $134.10B | |
| LIVN Livanova Plc | $5.02B | |
| ITGR Integer Holdings Corp | $4.31B | |
| AXGN Axogen, Inc. | $2.91B | |
| TMDX Transmedics Group, Inc. | $2.39B | |
| CNMD Conmed Corp | $1.57B | |
| CBLL Ceribell, Inc. | $998M | |
| INMD Inmode Ltd. | $770M | |
| CV Capsovision, Inc | $310M | |
| ELMD Electromed, Inc. | $224M | |
| FOCL Edap Tms Sa | $159M | |
| STXS Stereotaxis, Inc. | $105M | |
| ECOR Electrocore, Inc. | $79M | |
| OM Outset Medical, Inc. | $77M | |
| NRXS Neuraxis, Inc | $77M | |
| HYPR Hyperfine, Inc. | $73M | |
| POCI Precision Optics Corporation, Inc. | $54M | |
| POSC Positron Corp | $54M | |
| QTI Qt Imaging Holdings, Inc. | $30M | |
| ITOC Itonic Holdings Ltd | $12M | |
| IRIX Iridex Corp | $12M | |
| GTHP Guided Therapeutics Inc | $10M | |
| NDRA Endra Life Sciences Inc. | $8M | |
| ADMT Adm Tronics Unlimited, Inc. | $6M | |
| NUWE Nuwellis, Inc. | $2M | |
| ESMC Escalon Medical Corp | $1M | |
| NXL Nexalin Technology, Inc. | $1M | |
| YBGJ Yubo International Biotech Ltd | N/A |
EMERYVILLE, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (NASDAQ: VANI), an innovative, near-clinical stage biopharmaceutical company that is developing novel, miniature, long-term therapeutic ...
Detailed price information for Vivani Medical Inc (VANI-Q) from The Globe and Mail including charting and trades.
ALAMEDA, Calif., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting ...
Our AI scores Vivani Medical, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
For VANI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -8.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 10.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Vivani Medical, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
29 issuers in our coverage, VANI included, share the SEC industry code Electromedical & Electrotherapeutic Apparatus. The largest are: Medtronic Plc (MDT), Livanova Plc (LIVN), Integer Holdings Corp (ITGR), Axogen, Inc. (AXGN), Transmedics Group, Inc. (TMDX), Conmed Corp (CNMD).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.
